TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Benchmark Genetics Norway AS
Closing information (x1000 NOK)
Closing information | 2023/09 | 2022/09 | 2021/09 |
Turnover |
414,588
|
355,834
|
291,449 |
Financial expenses |
5,939
|
5,831
|
5,132 |
Earnings before taxes |
54,123
|
40,710
|
19,421 |
Total assets |
321,814
|
326,171
|
327,271 |
Current assets |
88,320
|
95,191
|
98,453 |
Current liabilities |
99,494
|
81,674
|
57,096 |
Equity capital |
156,239
|
114,124
|
82,044 |
- share capital |
9,000
![]() |
9,000
![]() |
9,000 |
Financial ratios
Fiscal year | 2023/09 | 2022/09 | 2021/09 |
Solvency |
48.5%
|
35.0%
|
25.1% |
Turnover per employee | |||
Profit as a percentage of turnover |
13.1%
|
11.4%
|
6.7% |
Return on assets (ROA) |
18.7%
|
14.3%
|
7.5% |
Current ratio |
88.8%
|
116.5%
|
172.4% |
Return on equity (ROE) |
34.6%
|
35.7%
|
23.7% |
Change turnover |
58,754
|
64,385
|
52,393 |
Change turnover % |
17%
|
22%
![]() |
22% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/09 | 2022/09 | 2021/09 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.